Clinical Trial Update: Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer [NA]

View source ↗

Summary

Clinical trial update on whole-body [18F]FES PET imaging for metastatic estrogen receptor-positive breast cancer using dynamic and test-retest protocols. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FES (18F-fluoroestradiol)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Breast Cancer | NA | Status: RECRUITING